DOI: 10.1055/s-00000028

International Journal of Sports Medicine

References

Bahary N, Wang-Gillam A, Haraldsdottir S. et al.
Phase 2 trial of the IDO pathway inhibitor indoximod plus gemcitabine / nab-paclitaxel for the treatment of patients with metastatic pancreas cancer.

J Clin Oncol 2018;
36: 4015-4015

Download Bibliographical Data

Search in:
Access: